
Hundreds of Thousands of Breast Cancer Deaths Averted Since 1989
This study demonstrates the significance and efficacy of breast cancer screenings for prevention and early intervention.
Researchers at the University of Colorado School of Medicine analyzed breast cancer mortality and female population data from the Surveillance, Epidemiology, and End Results (SEER) program. Data focusing on women aged 40 to 84 years over the past 3 decades were gathered in order to estimate the number of breast cancer deaths averted by screening mammography and improved treatment since 1989.
According to
"Recent reviews of mammography screening have focused media attention on some of the risks of mammography screening, such as call-backs for additional imaging and breast biopsies, downplaying the most important aspect of screening ­— that finding and treating breast cancer early saves women's lives. Our study provides evidence of just how effective the combination of early detection and modern breast cancer treatment have been in averting breast cancer deaths," study author R. Edward Hendrick, PhD, said in the release.
The investigators calculated that mammography and improved treatment decreased the expected mortality rate of breast cancer in 2018 by 45.3% to 58.3%.
According to Dr Hendrick, about half of US women over 40 years of age receive regular screening mammography. "The best possible long-term effect of our findings would be to help women recognize that early detection and modern, personalized breast cancer treatment saves lives and to encourage more women to get screened annually starting at age 40."
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































